PVH
32
2
REGN
59
2
PNR
51
3
GOOGL
47
4
STX
69
2
DHR
66
2
ITW
37
-2
SIG
46
2
RIG
40
2
THC
47
2
DRI
66
2
XEL
37
-2
ADT
50
2
GS
76
6
DTE
38
-4
MAR
71
3
T
23
2
APH
56
7
VFC
70
2
ORCL
33
7
PVH
32
2
REGN
59
2
PNR
51
3
GOOGL
47
4
STX
69
2
DHR
66
2
ITW
37
-2
SIG
46
2
RIG
40
2
THC
47
2
DRI
66
2
XEL
37
-2
ADT
50
2
GS
76
6
DTE
38
-4
MAR
71
3
T
23
2
APH
56
7
VFC
70
2
ORCL
33
7
Financhill
Back

PT Kalbe Farma Tbk 10K Form

Sell
20

PTKFF
PT Kalbe Farma Tbk

Last Price:
$0.07
Seasonality Move:
5.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PTKFF News And Ratings

See the #1 stock for the next 7 days that we like better than PTKFF

PTKFF Financial Statistics

Sales & Book Value

Annual Sales: $2.1B
Cash Flow: $40.4M
Price / Cash Flow: 19.14
Annual Sales: $0.03
Price / Book: 2.36

Profitability

EPS (TTM): 0.00470
Net Income (TTM): $218.2M
Gross Margin: $790.8M
Return on Equity: 14.32%
Return on Assets: 11.86%

PT Kalbe Farma Tbk Earnings Forecast

Key PT Kalbe Farma Tbk Financial Ratios

  • The Gross Profit Margin over the past 20 years for PTKFF is 38.40%.
  • The Selling, General & Administrative Expenses for PTKFF have been equal to 25.49% of Gross Profit Margin.
  • The Research & Development expenses have been 1.17% of Revenue.
  • The Interest Expense is 2.13% of Operating Income.
  • The Net Earning history of PTKFF is 9.95% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 13 years.

PT Kalbe Farma Tbk Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PTKFF
Website: kalbe.co.id

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 3.85
Quick Ratio: 2.11

Price-to-Earnings

Trailing P/E Ratio: 16.31
Forward P/E Ratio: 0

PTKFF Technical Analysis vs Fundamental Analysis

Sell
20
PT Kalbe Farma Tbk (PTKFF) is a Sell

Is PT Kalbe Farma Tbk a Buy or a Sell?